Search
Now showing items 711-717 of 717
Patients with early stage chronic lymphocytic leukemia: new risk stratification based on molecular profiling
(Taylor & Francis Ltd, Abingdon, 2011)
We investigated molecular and biological parameters reflecting the biology of chronic lymphocytic leukemia (CLL) that may help us to predict the time to first treatment (TTT). A group of 33 patients with newly diagnosed ...
Prognostic value of vascular endothelial growth factor (VEGF) serum level and immunohistochemical expression in non-treated patient with chronic lymphocytic leukemia
(Pergamon-Elsevier Science Ltd, Oxford, 2010)
Serum level of vascular endothelial growth factor (vegf) as prognostic parameter in untreated patients with b-cell chronic lymphocytic leukemia
(Ferrata Storti Foundation, Pavia, 2010)
Microarray and Proteomic Analysis of Myeloproliferative Neoplasms
(Amer Soc Hematology, Washington, 2011)
Significance of new prognostic markers in early stage chronic lymphocytic leukemia patients
(Elsevier, Amsterdam, 2011)